Stay updated on Nivolumab Maintenance in Aggressive Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Maintenance in Aggressive Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Maintenance in Aggressive Lymphoma Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    0.3%
    Check dated 2025-05-08T13:47:37.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:13:59.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new version of the study protocol, including changes to the treatment regimen for high-risk aggressive B-cell lymphoma patients, specifically the dosing schedule for nivolumab. Additionally, the principal investigator's name has been clarified.
    Difference
    44%
    Check dated 2025-04-16T20:27:29.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T13:53:22.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-25T17:23:39.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-24T23:06:09.000Z thumbnail image

Stay in the know with updates to Nivolumab Maintenance in Aggressive Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Maintenance in Aggressive Lymphoma Clinical Trial page.